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AntibunchingGangliosides located at the outer leaﬂet of plasmamembrane aremolecules that either participate in recognizing
of exogenous ligandmolecules or exhibit their own receptor activity,which are both essential phenomena for cell
communication and signaling as well as for virus and toxin entry. Regulatorymechanisms of lipid-mediated rec-
ognition are primarily subjected to the physical status of the membrane in close vicinity of the receptor.
Concerning the multivalent receptor activity of the ganglioside GM1, several regulatory strategies dealing with
GM1 clustering and cholesterol involvement have been proposed. So far however, merely the isolated issues
were addressed and no interplay between them investigated. In this work, several advanced ﬂuorescence tech-
niques such as Z-scan ﬂuorescence correlation spectroscopy, Förster resonance energy transfer combined with
Monte Carlo simulations, and a newly developed ﬂuorescence antibunching assay were employed to give a
more complex portrait of clustering and cholesterol involvement in multivalent ligand recognition of GM1.
Our results indicate that membrane properties have an impact on a fraction of GM1 molecules that is not avail-
able for the ligand binding. While at low GM1 densities (~1 %) it is the cholesterol that turns GM1 headgroups
invisible, at higher GM1 level (~4 %) it is purely the local density of GM1molecules that inhibits the recognition.
AtmediumGM1 content, cooperation of the two phenomena occurs. This article is part of a Special Issue entitled:
Nanoscale membrane organisation and signalling.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Glycosphingolipids (GSLs), ceramide-derived lipid moieties with an
oligosaccharide attached to the headgroup, are often localized on cell
surfaces where they act as receptor molecules for various protein
ligands. Therefore GSLs are often involved in cellular signaling and com-
munication as well as in virus or toxin entry. GSLs (ganglioside GM1 in
particular) serve not only as receptor molecules directly but were also
found to modulate function of other membrane receptors usually by
association with the particular membrane protein [1].scale membrane organisation
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políčková),Apart from the regulation of receptor ligand recognition occurring at
the level of GSL expression, several regulatory mechanisms based on
membrane lipid-lipid interactions have been proposed.
GSLs due to the ceramide hydrophobic moiety are known to prefera-
bly interact with sphingomyelins which results in their segregation into
liquid ordered (Lo) phase inmodel membranes or into the so called lipid
“rafts” in living cells. This potentially gives rise to the biophysical, lipid-
mediated origin of a signaling regulatory mechanism. For example,
clustering of GM1 containing lipid rafts has been shown to signal β1
integrins in T-cells and by that activate strengthening of their adhesion
[2].
Furthermore, cholesterol has been indicated to have an essential role
in regulating the receptor activity of GSLs [3]. Cholesterol-related
“masking” of GSLs turning themunavailable for ligands has been related
to a tilt of glycolipid headgroup. Cholesterol was predicted to make
the oligosaccharide moiety lean over the membrane surface instead of
sticking out of the bilayer, which reduces the surface recognition
capacity. This was, for example, demonstrated to work during sperm
activation [4].
851R. Šachl et al. / Biochimica et Biophysica Acta 1853 (2015) 850–857Apart from the interactions of the aglycone there is also a signiﬁcant
contribution of the glycane-glycane binding in the headgroup region.
The network of hydrogen bonds stabilizes the cooperative interactions
between the sugar residues allowing them to cluster even in phosphati-
dylcholine bilayers. The clustering itself can serve as a regulatorymech-
anism of ligand recognition becoming especially important when the
multivalent ligand-receptor interaction is discussed. In the work of
Shi et al. [5], the regulation of pentavalent carbohydrate-protein
binding, represented by GM1 – cholera toxin B (CTxB), is demon-
strated on the model system of supported lipid bilayers. In the
GM1 clusters the distance between GM1 molecules was concluded
to not ﬁt the binding sites of CTxB anymore and thus some GM1
became unavailable.
As indicated, strategies regulating ligand recognition use various
mechanisms and apparently, in the complex system of cellular plasma
membrane, interplay between them most probably occurs resulting
from local variations in cholesterol, saturated lipids and/or GSLs con-
tent. The aim of this manuscript is to shed light on two aspects of the
regulation, particularly on cholesterol driven changes in GM1 availabil-
ity and on the tendency of GM1molecules to cluster. The clustering abil-
ity of GM1 is promoted by oligo-saccharide moieties in the headgroup
region. Thus, in order to address speciﬁcally the sugar related behavior,
we have performed our experiments on DOPC containing membranes,
where tail-to-tail interaction are lowered compared tomixtures contain-
ing saturated lipids. In the model system of giant unilamellar vesicles
(GUVs) consisting of DOPC/cholesterol (Chol)/GM1, we utilize i) Förster
resonance energy transfer (FRET) between various FRET pairs in combi-
nation with Monte Carlo (MC) simulations, and ii) Z-scan ﬂuorescence
correlation spectroscopy (FCS) [6] in order to characterize the size and
nature of GM1 clusters in cholesterol containing and cholesterol free
membranes.
Next,we develop a binding assay based on the counting of individual
emitters via a ﬂuorescence antibunching technique [7], which allows for
measuring the number of GM1 lipids in the membrane as well as the
number of bound toxins.
By this we can clearly demonstrate that clustering of GM1 oc-
curs even in bilayers containing solely DOPC and, in addition to
that, it is completely independent on the cholesterol content.
While cholesterol does not seem to have an impact on the aggrega-
tion of GM1molecules, its content is still essential for GM1 recogni-
tion by CTxB. We show however that the GM1 clusters change their
nature at increased GM1 levels (~4 %) as the GM1 molecules
become denser and thus prevent sugar headgroups from being
available for the binding of the pentavalent CTxB ligand. At this
stage, it is the clustering mechanism that prevails over the choles-
terol modulation of GM1 and cholesterol is no longer involved in
the ligand recognition.
Eventually we explore the role of the ligand in GM1 organization.
We show that upon CTxB binding, the character of the nano-clusters
changes substantially. While their size remains the same, their rigid-
ness and permeability becomes signiﬁcantly affected resulting from
an increased GM1/DOPC ratio.
2. Materials and methods
2.1. Chemicals
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), GM1 Ganglioside
(Ovine brain sodiumsalt), cholesterol, and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(cap biotinyl) (biotinyl Cap PE) were pur-
chased from Avanti Polar Lipids (Alabaster, AL, U.S.A.) and used without
further puriﬁcation. DiIC18(5)-DS (DiD), Alexa Fluor® 488 labeled CTxB
(CTxB-488)were purchased from Invitrogen (Carlsbad, CA). Streptavidin,
biotin labeled bovine serum albumin (biotin-BSA), and CTxB were
purchased from Sigma (St. Louis, MO). DOPE was covalently labeled by
Atto655-NHS-ester (Siegen, Germany) and puriﬁed by adsorptionchromatography on silica gel column Kieselgel 60 (Merck, Whitehouse
Station, NJ, U.S.A.) in chloroform/methanol/water (60/25/4) eluent.
Synthesis of FL-BODIPY-GM1 and of 564/570-bodipy-GM1 is described
elsewhere [8].
2.2. GUV preparation
GUVs for ﬂuorescence microscopy were prepared by the electrofor-
mation method using titanium chambers as described by Angelova
et al. [9] Lipid mixtures were made from stock solutions in chloroform.
The overall amount of all lipids (100 nmol in approximately 200 μL
of chloroform) together with the labeled lipids was spread onto two
hollowed titaniumplateswhichwere placed on a heater plate at approx-
imately 50 °C to facilitate solvent evaporation and subsequently put
under high vacuum for at least 1 h for evaporation of remaining traces
of solvent. The lipid-coated plates were assembled using one layer of
Paraﬁlm for insulation [10]. The electroswelling chamber was ﬁlled
with 1 ml preheated sucrose solution (100 mM sucrose, and osmolarity
of 103 mOsm/kg) and sealed with Paraﬁlm. An alternating electrical
ﬁeld of 10 Hz rising from 0.02 V to 1.1 V (peak-to-peak voltage) in the
ﬁrst 45 min was applied and then kept at 1.1 V for additional 2.5 h
at 55 °C, followed by 30 min of 4 Hz and 1.3 V to detach the formed
liposomes. Finally, the GUVs were placed in a microscopy chamber con-
taining glucose buffer (~80mMglucose, 10mMHEPES and 10mMNaCl,
pH 7.2)with an osmolarity of 103 mOsm/kg. All lipidmixtures contained
2 mol % of biotinyl Cap PE for immobilization of GUVs on BSA-biotin/
streptavidin coated bottom of the chamber.
For the FCS experiments probe-to-lipid ratio was around 1:100000,
i.e. 0.0001 %. For the FRET experiments the donor(acceptor)-to-lipid
ratio 1:1000, i.e. 0.01 % (1:200, i.e. 0.5 %) was chosen in the case of
g-GM1/DiD pair; and 1:200, i.e. 0.5 % for both donor- and acceptor-to-
lipid ratio in the case of g-GM1/r-GM1 pair.
2.3. LUV preparation
For LUV formation the appropriate mixture containing 10-6 mol of
DOPC/Chol (at given ratio) and 10-8 to 4 × 10-8 mol of GM1 was pre-
pared in chloroform. GM1 contained a labelled lipid (Atto655-DOPE) in
a well-deﬁned ratio (GM1/Atto655-DOPE, 606:1) in order to be able to
estimate the amount of GM1 via antibunching. The chloroform was
evaporated using a rotary evaporator and the lipid ﬁlm re-hydrated
with 1 mL buffer solution (~80 mM glucose, 10 mM HEPES and 10 mM
NaCl, pH 7.2). The turbid solution containing multilamellar vesicles
was extruded 10 times with use of 100 nm ﬁlters in a LIPEX extruder
(Northern Lipids Inc, Canada) [11].
2.4. FCS and FLIM-FRET
Both types of measurements were performed on a home-built con-
focal microscope consisting of an inverted confocal microscope body
IX71 (Olympus, Hamburg, Germany). Pulsed diode lasers (LDH-P-C-
470, 470 nm, and LDH-D-C-635, 635 nm PicoQuant, Berlin, Germany)
with 10 MHz repetition rate each were used. The lasers were pulsing
alternatively in order to avoid artifacts caused by signal bleed-through.
The laser light was coupled to a polarization maintaining single mode
optical ﬁber and at the output re-collimated with an air space objective
(UPLSAPO 4X, Olympus). The light was up-reﬂected to a water immer-
sion objective (UPLSAPO 60x, Olympus) with a 470/635 dichroicmirror.
The signal was split between two single photon avalanche diodes using
515/50 and697/58bandpassﬁlters (ChromaRockingham, VT) for green
and red channel, respectively. In the case of FCS measurements, laser
intensity at the back aperture of the objective was around 10 μW for
each laser line. The z-scan was performed on the top of selected
unilamellar liposomes. Membrane was ﬁrst placed to the laser beam
waist, then moved 1.5 μm below the waist and consequently vertically
scanned in 20 steps (150 nm spaced). At every position a 60 second
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where [6b]. For the FLIM-FRET measurements the lasers’ intensities
were chosen low enough to avoid pile-up effect, i.e. around 1 μW for
470 nm and less than 0.1 μW for 635 nm. Each GUV was scanned at
the cross-section and an image of 512 × 512 pixels (0.6 ms/pixel) was
acquired. Details of the MC simulations are given in SI.
2.5. Antibunching
The confocal setup for antibunchingwas the same as for FCSmeasure-
ments. Either 470 nm or 635 nm pulsed diode laser was used for excita-
tion with repetition frequency 20 MHz. To achieve detection of two
nanosecond and sub-nanosecond delayed consecutive photons the signal
was split between two independent detectors connected to independent
electronic circuits (Hydraharp, PicoQuant, Germany). Two identical emis-
sion ﬁlters were placed in front of each detector (515/50 for green emis-
sion and 697/58 in combination with a 775 short pass ﬁlter, to block the
far IR light, for red emission) to prevent detector afterglow. The autocor-
relation function is calculated by crosscorrelating the signal from the two
detectors. Correlation and subsequent data analysis was done with
home-written scripts in Matlab (Mathworks, Natick, MA). Details are
given in SI.
2.6. Binding assay
100 nmLUVs consisting of DOPC/Chol/GM1 in a given ratiowere pre-
pared. Stock solution of GM1 contained a deﬁned fraction of Atto655-
DOPE. Number of Atto655-DOPE was measured via antibunching. This
allowed for estimating how many GM1 molecules were present in a
single LUV. Then the LUV solution was titrated with a mixture of
Alexa488-labeled/non-labeled CTxB (1/60). During the titration the
number of labeled CTxB was evaluated. Once the surface became fully
saturated by CTxB the maximum of labeled toxin per LUV was reached
and the average number of emitters per complex started to drop due to
contribution of unbound labeled CTxB from the solution. Eventually,
information on the amount of available GM1 and amount of bound
toxin was obtained.
3. Results and discussion
3.1. Clustering of GM1 in presence/absence of cholesterol
3.1.1. FRET combined with MC simulations
To address the issue of GM1 clustering, FRET between FL- and 564/
570-BODIPY-head-labeled GM1 (g-GM1 = green-GM1, r-GM1 = red-Fig. 1. Structures of FL- and 564/570-BODIPY-head-labeled GM1 (g-GM1, r-GM1).GM1) [8a,12] molecules was investigated. The structures of the donor
and acceptor are given in Fig. 1.
As long as donors (g-GM1) and acceptors (r-GM1) are homoge-
neously distributed in the membrane, the donor ﬂuorescence decay
becomes shortened as a result of donor-acceptor interactions occurring
at various distances within the samemembrane leaﬂet as well as across
themembrane. Such situation, assigning every donor-acceptor distance
a certain probability of energy transfer, is described analytically via the
Baumann-Fayer (B-F) model [13]. The electric dipole moments of the
probes are supposed to be randomly distributed or reorient fast with
respect to FRET. As long as the donor decay can be reconstituted with
the B-F model and providing reasonable acceptor concentrations the
distribution of donors and acceptors can be, within the resolution capa-
bility of FRET [14], considered homogenous. Once the GM1 containing
clusters (domains) are formed, g- and r-GM1 molecules are dragged
closer to one another, the level of FRET increases and fails to follow
the B-F model. Instead, MC simulations [15] accounting for an inhomo-
geneous distribution of donors and acceptors are carried out providing
information on the size of the clusters and overall percentage of the
bilayer occupied by those clusters.
Both the DOPC and DOPC/Chol (70/30) GUVswere labeledwith a 1:1
mixture of g-GM1 and r-GM1 (1 % of both lipids in total). The donor ﬂuo-
rescence decaywas in both the discussed cases well described by the B-F
model suggesting a homogeneous distribution of g- and r-GM1 mole-
cules. Upon adding non-labeled GM1 molecules the donor decay be-
comes signiﬁcantly faster, i.e. FRET between the g-GM1 and r-GM1
increases suggesting that GM1 containing domains are formed (Fig. 2a,
Fig. S4a). The donor decay changes upon addition of 1 % of GM1 and
then remains unchanged up to relatively high content of GM1 (~8 %).
The fact that the change in FRET occurs instantly in narrow range of
added GM1 and is not followed by further development suggests:
i) labeled GM1 molecules do not constitute domains on their own, yet
interact with them once they are established; ii) the formed domains
do not change in size and overall amount when excess of GM1 is
added, suggesting that their nature is affected by the increasing GM1
content.
To conﬁrm i), we have used an alternative FRET pair consisting of
green (Me)4bodipy-tail-labeled lipid (B7PC) [16] as a donor and r-GM1
as an acceptor. Use of this FRET pair allowed us for reducing the amount
of labeled GM1 to one half (0.5 %). B7PC most probably does not show
any preference in partitioning (similar to DiD, see further). Therefore,
when domains are formed, contributions from the domains (increased
FRET) and from the outside membrane region (lowered FRET) are to
be expected. The latter one would prevail as more B7PC molecules are
involved. The change in FRET occurs already at 0.5 % added GM1 and
does not signiﬁcantly develop with further increase of GM1 (see Fig. S6Fig. 2. Donor ﬂuorescence decays of g-GM1. a) FRET between g-GM1 (1/200, 0.5 %)
and r-GM1(1/200, 0.5 %) inDOPCbilayer at 0% (black), 1 % (red), 4 % (blue) addedunlabeled
GM1, saturationwith CTxB (olive). b) FRET between g-GM1 (1/1000, 0.1 %) and DiD (1/100,
1 %) in DOPC bilayer at 0 % (black), 2 % (red) added unlabeled GM1. Ratio given in brackets
corresponds to the donor (acceptor) – lipid ratio.
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amount of labeled GM1 does not impact the changes occurring when
non-labeled GM1 is added, i.e. it is evident the labeled GM1 does not
constitute the domains, but becomes incorporated in them when they
are established. In addition to that, the experiment proves that GM1 clus-
tering occurs already at concentrations below 1 %, which can be barely
but still visible with the g-GM1/r-GM1 pair as the amount of the label
necessary exceeds the amount of the added GM1 (see Fig. S5 in SI).
Considering the g-GM1/r-GM1pair, the donor decays displaying FRET
enhancement were analyzed by means of MC simulations (Table 1). The
size as well as the average area domains occupy does not change with
increasing level of GM1. Both the domain radius of around 5-7 nm and
the area they occupy (~40 %), as well as the fact that there is no change
of the two parameters when more GM1 is present seems to be in accor-
dance with the available AFM data acquired for supported lipid bilayers
[5]. The study of Shi et al give the AFM based diameters of the domains
as follow: 13.6 nm for 1 % GM1, 15.3 nm for 3 % GM1, and 18.6 nm for
5 % GM1, which we ﬁnd well corresponding to our results of the FRET
data. Furthermore, visual inspection of the AFM images given in the
discussedwork also suggests that the overall domain area exceeds signif-
icantly the GM1 content in the bilayer.
The experiment was also performed with POPC replacing the DOPC
lipid (see Fig. S7 in SI). The extent of the FRET change upon GM1 addi-
tion is slightly lower when POPC is used. Fit results in Table 1 suggest
that the domains are larger in both the cholesterol free and cholesterol
containing systems. While the difference between POPC and DOPC is
rather small, it suggests that the increasing level of saturated lipids
stabilize the domains in the tail region. While at low level of saturat-
ed lipids, the domains formation is solely driven by GM1 and its
sugar-related behavior, at larger level of lipid saturation, it will be
the saturated lipids that would govern domain creation and their
properties.
Table 1 provides also estimated number of individual lipids present
in the domains. The estimation assumed that all GM1 molecules are
present in the domains, that cholesterol fraction is the same in the
domains and outside of them, that the average area per lipid is 72 Å2
for cholesterol free bilayer and 64 Å2] for bilayer containing 30 % of
cholesterol [17]. GM1 contribution to the overall area was neglected.
The overall surface covered by domains, which reaches around 40 %
even in the systems containing only 1 % of GM1, is worth discussion. The
area the domains occupy is largely subjected to partitioning of the
labeled GM1 between the GM1 domains and the outside bilayer. Since
such knowledge would be hard to obtain, we run our MC simulations
for several values of Kd. The endeavor to obtain lower, intuitively more
appropriate, domain areas failed as ﬁtting provided us with shallow
chi^2 minima or did not converge at all. Moreover, not only MC-FRET
but also literature available AFM images of GM1 containingmembranes
suggest the presence of domainswith overall area largely exceeding theTable 1
Values of radii and overall domain areas obtained from MC-simulated ﬁtting of FRET data for
binding. Number of lipids/CTxB molecules estimated for domains of a given radius and overall
DOP
POPC⁎/%
Chol/% Added
GM1/%
CTxB FRET
pair
Radius/nm Area/% N
l
D
P
100 0 1;4;8 0 g-/r-GM1 5-7 35-45 3
70 30 1;4;8 0 g-/r-GM1 5-7 35-45 2
100⁎ 0 4 0 g-/r-GM1 10 45 8
70⁎ 30 4 0 g-/r-GM1 7-8 45-55 3
100 0 4 saturated g-/r-GM1 8 55 5
70 30 4 saturated g-/r-GM1 8 55 4
100 0 1 saturated Alexa488-CTxB/DiD 7 50 4
70 30 1 saturated Alexa488-CTxB/DiD 4,5 35 1
100 0 4 saturated Alexa488-CTxB/DiD 6 45 3
70 30 4 saturated Alexa488-CTxB/DiD 6 45 2
⁎ Values obtained for POPC.amount of GM1 in the membrane [5]. The evidence that 10 % GM1
causes formation of ﬂower-shaped domains spanning over more than
40 % of DPPC/GM1 monolayer [18] conﬁrms the high involvement of
PC molecules in the discussed structures.
Assuming that all GM1 molecules compose the GM1 domains, the
ratio DOPC/GM1 in the domains can be roughly estimated. It starts at
about ~ 20/1 at 1 % GM1 and continues down to 4/1 at 8 % GM1 (see
Table 1). Literature suggests non idealmixing of GM1 and phosphatidyl-
cholines (PCs) resulting in condensing effect of GM1 [18]. This has been
attributed to the complexes GM1 forms with PCs with a stoichiometry
of about 3 PC molecules to 1 GM1. With regard to the literature and as
well as to the geometry of GM1, the ratioswe observe far exceed theoret-
ical number of PCs that may be stabilized by single GM1 molecule. A
computational study of GM1 in fully hydrated DOPC bilayer [19] shows
that GM1 molecules not only condense headgroup area of DOPC mole-
cules in the ﬁrst coordination sphere of GM1 (containing 2-3 DOPCmol-
ecules) but also shift the average mass of DOPC inside the bilayer due to
the sugar moiety buried in the headgroup region of PCs. This results in a
locally perturbedmembrane thatmay require several DOPCmolecules to
accommodate such a perturbation to the remaining bilayer, whichmight
explain the higher involvement of DOPC. Eventually merging of GM1-
caused perturbations may be promoted in order to minimize the overall
energetic penalty spent on the accommodation of thewhole pool of GM1
rather than individuals. The fact that increasing amount of GM1 does not
cause further development in FRET efﬁciency suggests that the pools of
stabilized GM1 perturbations can accommodate more GM1 molecules
as long as the ratio between DOPC and GM1 is below the stoichiometry
of a complex of GM1 and PCs in the ﬁrst coordination sphere (~2-3).
The idea that GM1 domains in DOPC and DOPC/Chol mixtures are
rich in PC molecules is further supported by FRET experiments made
on a pair consisting of g-GM1 (donor) and DiD (acceptor). Fig. 2b
(Fig. S4b) shows that energy transfer from g-GM1 to DiD is insensitive
to the presence of extra unlabeled GM1 revealing that the acceptor
distribution has not been altered upon domain formation. No preferen-
tial partitioning of DiD (as well as of Atto655-DOPE, for which the very
same result was observed with g-GM1 as acceptor, data not shown)
indicates high permeability of the GM1 domains that can only bemain-
tained if they are mainly composed of PC molecules, considering that
GM1 is a ceramide derivative preferring higher lipid ordering.
FRET experiments (g-GM1/r-GM1, g-GM1/DiD) performed in GUVs
composed of DOPC and cholesterol (up to 30 %) showed a behavior very
similar to the one observed for cholesterol free GUVs (see Table 1). No
evidence that cholesterol has an impact on GM1 clustering also indirectly
supports the mentioned idea of GM1 pools containing almost isolated
GM1 molecules. If GM1 molecules were in closer contact, cholesterol
with its inverse cone-like structure would stabilize the locally enhanced
number of GM1 cones, which would most probably result in a GM1
dependency of the overall domain area. As this does not occur, it followsvarious donor-acceptor pairs at different membrane compositions, before and after CTxB
area.
umber of lipids/toxin molecules in the domains. Number of lipids holds for both
eaﬂets.
OPC
OPC⁎
Chol GM1 labeled
GM1
total GM1 CTxB
pentamer
DOPC POPC⁎/all GM1
14 0 8; 31; 63 8 16; 39; 72 NA 20; 8; 4
47 106 9; 35; 71 9 18; 44; 80 NA 14; 6; 3
72⁎ 0 78 19 97 NA 9⁎
86⁎ 166 44 11 55 NA 7⁎
58 0 39 10 49 2-3 11
40 188 44 11 55 2-3 8
27 0 9 0 9 1 47
39 60 6 0 6 1 23
14 0 28 0 28 2-3 11
47 106 32 0 32 2-3 8
854 R. Šachl et al. / Biochimica et Biophysica Acta 1853 (2015) 850–857that DOPC remains the main partner of GM1 even when cholesterol is
available.
3.1.2. Diffusion measurements
Z-scan FCSmeasurements were performed to investigate changes in
diffusion of g-GM1 and DiD once the GM1 domains are established.
Fig. 3 shows that at approximately 2 % of GM1 the diffusion of both la-
beled molecules signiﬁcantly decreases. This conﬁrms the conclusions
made when discussing the FRET data: labeled GM1 as well as DiD – a
lipid tracer which is known to strongly avoid partitioning into ordered
lipid areas – interact with pools of GM1 molecules causing their diffu-
sion to slow down. The drop in diffusion is observed independently on
the presence of cholesterol, which is in accord with the FRET experi-
ments. Below 2 % GM1 we do not observe changes in diffusion. This
however does not exclude domain formation at even lower level of
GM1 as we most probably get to the resolution limit of our approach.
The diffusion of g-GM1 shows no change with the increase of GM1
concentration from 2 % to 4 %. This suggests, and is supported by the
FRET data, that the domains can accommodate the increasing number
of GM1 molecules without signiﬁcant changes in GM1 diffusion. GM1
molecules still move relatively independent of each other inside the
domain.
3.2. Receptor activity of GM1
Recognition of multivalent ligands (CTxB) by GM1 molecules could
be lowered if some GM1 molecules are “hidden” on the surface and
thus are not available for binding. As suggested in previous works, this
may arise from clustering [5] of the receptor and/or tilting of its
headgroup [4]. In order to relate the overall number of GM1 to the num-
ber of CTxB bound to the GM1 containing surface we have designed a
ﬂuorescence antibunching based binding assay. In this case we apply
the antibunching experiment (i.e. detecting photon pairs delayed by
less than their ﬂuorescence lifetime, details are given in SI) on freely dif-
fusing molecular complexes of emitters in solution. The ﬁnal histogram
of the lag-times between two consecutive photons is an ensemble aver-
age of all transits of the individual complexes through the focal volume.
When approaching zero lag-times the probability of detecting a photon
pair decreases since oneof the emitters in the complex, once it has emit-
ted a photon, is turned off for several nanoseconds. The depth of the
zero lag-time decrease provides a read-out on the number of emitters
in the molecular complex.
The binding assay in this study is the following: large unilamellar
vesicles (LUVs) containing a given amount of GM1 in an investigated
lipid mixture are prepared. GM1 stock solution contains Atto655-
DOPE in a given deﬁned ratio, which serves as a GM1 tracer allowing
for determination of the amount of GM1 per LUV. The ratio was opti-
mized so that each LUV contains maximum ~ 10 labeled lipids. With
the help of antibunching, labeled tracer molecules per LUV are countedFig. 3. Dependence of diffusion coefﬁcient of g-GM1 (left) and DiD (right) on the amount
of GM1 for DOPC (circles) and DOPC/Chol (70/30) (squares) bilayer.which provides a good overview on the amount of total GM1 in the
LUVs. At the used concentration range the number of tracer molecules
per LUV linearly scaled with increasing concentration of the tracer.
This conﬁrms that LUVs are molecular complexes large enough to pre-
vent processes such as singlet-singlet annihilation that would “mask”
some emitters [20]. The antibunching experiment done with the tracer
molecule additionally conﬁrms the unilamellar character of the LUVs, as
the number of the tracermolecules per LUV detected by antibunching is
in agreement with the estimated number assuming the unilamellarity.
Further, the unilamellarity was tested by quenching experiments (see
Fig. S3).
Then, the LUVs are titrated with a mixture of labeled/non-labeled
CTxB and in every titration step the total number of emitting CTxB per
LUV is counted. Since the dissociation constant for GM1-CTxB com-
plexes is very low (~10-11 – 10-12 mol/L) [21], the GM1 containing sur-
face is ﬁrst fully saturated with the toxin and then, when no binding
sites are available, free toxin appears in the solution. The titration
curve (i.e. the dependence of emitting CTxB per LUV on the amount of
added CTxB mixture) passes a maximumwhen all available GM1 lipids
are involved and is followed by a sharp decrease caused by the contribu-
tion of non-complexed CTxBmolecules from the solution to the ﬂuores-
cence signal. Finally, the total number of receptor molecules as well as
the total number of bound ligands is obtained.
Eventually, the performed titration experiments can also be evaluat-
ed in classical FCS-based manner, the results are in perfect agreement
with the evaluation of antibunching (Fig. S2 in SI and corresponding
discussion).
Antibunching was performed on LUVs containing 1 % of GM1. As we
have shown already, at this level GM1 molecules are organized into
domains but the amount of neighboring DOPC molecules is still high
keeping them independent from one another. Fig. 4a depicts titration
curves obtained for samples of LUVs containing various amounts of
GM1. While the x-axis displays consumption of CTxB relative to the
amount of GM1 added at sample preparation, the y-axis gives the ratio
between the number of the toxin bound emitters (Alexa488) per molec-
ular complex (LUV) and the number of GM1-tracingmolecules (Atto655-
DOPE) per LUV, both measured by antibunching. In other words, y-axis
serves as a measure of capacity of LUV surface to bind the ligand which
refers to the availability of GM1 for the recognition process. Both the
toxin consumption as well as the titration maximum suggest that at 1 %Fig. 4. a) Titration curves of GM1 containing LUVs with CTxB. x-axis stays for the ratio
between overall added CTxB and GM1 concentrations. y-axis (nrel) depicts number
of antibunching-counted Alexa488 emitters (CTxB) divided by the number of tracer
molecules per LUV, for each investigated lipidmixture.Maximum nrel is directly proportion-
al to the capacity of GM1 on the LUVs’ surface to bind CTxB. The following lipid mixtures
were investigated: DOPC + 1 % GM1 (DOPC/Chol/GM1 = 99/0/1 mol %) (black circles),
DOPC/Chol (70/30) + 1 % GM1 (DOPC/Chol/GM1 = 69.3/29.7/1 mol %) (red circles),
DOPC + 4 % GM1 (DOPC/Chol/GM1 = 96.2/0/3.8 mol %) (green squares), DOPC/Chol
(70/30) + 4 % GM1 (DOPC/Chol/GM1 = 67.3/28.8/3.8 mol %) (orange squares).
b) Maximum of the titration curve depicted as a function of the GM1 content for system
without (black squares) and with cholesterol (red circles).
Fig. 5. FRET experimentsmadewith Alexa488-labeled CTxB (donor) andDiD (acceptor) in
GUVs. Donor ﬂuorescence decays in systems containing a) 1 % GM1, and b) 4 % GM1.
Decays for system without cholesterol (black) and with 30 % of cholesterol (red); CTxB
(monomer)-to-lipid ratio 0.0001 (no change caused by CTxB) (dotted curves), fully
saturated GM1 surface (solid curves).
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cholesterol free.
The situation becomes different at 4 % GM1 because i) cholesterol
content does not play role any more, CTxB binding is cholesterol insen-
sitive; and ii) the availability of GM1 at 4 % is reduced compared to 1 %.
This suggests that upon further addition of GM1 molecules the arrange-
ment of the gangliosides becomes tighter causing a poorer match to the
binding sites of the ligandwhich is also no longer sensitive to thepresence
of cholesterol.
Fig. 4b shows the dependence of the titration maxima as a function
of GM1 content. Apparently below 2 % of GM1 in the cholesterol free
LUVs, the GM1 availability remains unaltered with increasing GM1
density. However, with cholesterol the GM1 availability is lowered.
This suggests that the presence of cholesterol act cooperatively with
the effect of GM1 density as increasing density promotes the cholesterol
impact. The role of cholesterol seems to comprise not only the sug-
gested issue of the headgroup tilt4 but also several other general aspects
such as cholesterol condensing effect [17]. It is well known that not only
cholesterol but also GM1 condenses lipid bilayers [18,19], and it has
been shown that GM1and cholesterol tend to co-localize [22]. Therefore
cholesterol together with higher GM1 content may be responsible for
high GM1 density in the domains and possibly also for high level of
ordering. As it is the GM1 density that matters generally (also in the
bilayer that does not contain cholesterol), it is very likely that cholester-
ol ampliﬁes its impact. Also, reduced GM1 mobility in cholesterol
containing membrane may render GM1 molecules less adaptable to
the ligand binding sites.
In summary, the binding assays reveal that while cholesterol does
not seem to impact the size and amount of GM1 domains its role in
binding recognition is yet signiﬁcant. The effect of cholesterol is subject-
ed to the spatial density of clustered GM1 molecules. At low GM1
densities (1 %), a relatively little effect of cholesterol is observed,
which could be assigned to cholesterol’s ability to keepGM1headgroups
in the tilted conformation [4]. At increasing GM1 levels (1-2 %) choles-
terol causes a drop in GM1’s availability. Eventually, at even tighter
GM1 arrangements (corresponding to 4 %), GM1 density takes control
of its recognition behavior.
3.3. Ligand induced changes
Even thoughGM1organization apparently affects its ability to recog-
nize the ligand, bound ligands in response signiﬁcantly rearrange the
bilayer in the vicinity of GM1.
In order to address the impact of the ligand on GM1 organizationwe
carried out more FRET experiments on GUVs. First, we employed a FRET
pair consisting of Alexa488 labeled CTxB as a donor andDiD as an accep-
tor. As shown in the previous discussion, irrespective of GM1 domains,
DiD is homogeneously distributed in the GUVs’ bilayer. However,
Fig. 5 shows that upon saturating all available GM1 molecules with
ligands (mixture of labeled and non-labeled CTxB) the donor ﬂuores-
cence decay exhibits lowered FRET compared to the situation when
only less than 1 % of all GM1 was bound to a ﬂuorescent ligand. This
most importantly suggests that upon binding of the ligand the character
of the GM1 domains is changed because in this new situation DiD is
expelled from them, i.e. the domains are no longer fully permeable for
the lipid tracer.
Parameters resulting from theMC simulations of the FRET decays as
well as the estimation of number of individual lipids in the domains are
given in Table 1. It further predicts number of toxin molecules that can
at maximum bind to a domain, when number of GM1 in the domains
and/or size of thedomainswould be taken as a limiting factor. Assuming
that the used excess of CTxB is guaranteeing that all GM1 localized at the
outer surface of theGUVs is associatedwith the CTxB-lipid domains, our
data indicates that i) size of the domains aswell as the area they occupy
does not signiﬁcantly change upon CTxB binding; ii) at 1 % GM1 the
overall area occupied by toxin containing domains is lowered in thepresence cholesterol, while at 4 % GM1 cholesterol has no impact on
the ﬁnal distribution of donors and acceptors. The cholesterol effect on
the domain parameters is in accord with the binding assays performed
on LUVs.
Second, as a result of GM1 – ligand interaction the diffusion of DiD
and g-GM1 decrease upon CTxB addition (Table 2). Most probably the
observed ﬂuorescent moieties keep interacting with the CTxB-GM1
complexes at the interface, where molecules may experience curvature
which CTxB is known to impose on the bilayer [23].
More detailed analysis of the diffusivemotion given in Fig. S8 shows
that the slower diffusion of lipids upon CTxB binding represented by an
apparent diffusion coefﬁcient given in Table 2 accounts for a different
type of motion than free diffusion. The dependence of the residence
time onmean square displacement suggests a trapped diffusion, i.e. ran-
dom walk interrupted by staying still in the potential trap [24].4. Conclusions
In this manuscript the availability of ganglioside GM1 for multiva-
lent receptor-ligand recognition is discussed. A portrait unifying two
usually solely considered aspects of GM1 receptor activity such as its
clustering and cholesterol involvement is given.
We show that GM1 tends to cluster even in bilayers consisting of
pure DOPC at concentration lower than 1 %. There is moreover no
evidence that cholesterol would affect this behavior. MC simulations
of FRET predict domains of 5-7 nm radius that are extended over
more than 35 % of the entire bilayer area regardless of the amount of
GM1 present (up to ~ 8 %). This indicates that especially at lower GM1
concentrations these domains contain more than 3 DOPC molecules
per GM1, which are predicted to occupy the ﬁrst coordination sphere
of GM1 [19]. The excess of PCs in the GM1 domains suggests that PCs
are required to accommodate GM1 perturbed regions to the remaining
bilayer. Consequently the domains cannot be considered to be of liquid
ordered nature but rathermore asﬂuid pools containing almost isolated
GM1 molecules at low GM1 concentrations (below ~ 1 %).
The fact that GM1molecules are conﬁned in the pools allows for ﬁne
tuning of local GM1 density even at very low overall GM1 content (1 – 4
%) resulting in a powerful regulation of the multivalent recognition.
Signiﬁcant reduction of GM1 availability for the ligands can be accom-
plished by only a few percent elevation of GM1 content which makes
GM1 molecules already too dense for being efﬁciently recognized by
the ligand.
Table 2
Diffusion coefﬁcients of g-GM1 and DiD measured by Z-scan FCS for 4 % GM1 containing membranes in absence and presence (30 %) of cholesterol, before and after CTxB is added.
Dg-GM1 [μm2/s] St. dev. [μm2/s] DDiD [μm2/s] St. dev. [μm2/s]
DOPC + 4 % GM1
DOPC/Chol/GM1 = 96.2/0/3.8 mol %
8.02 2.74 8.28 2.55
DOPC + 4 % GM1+ CTxB
DOPC/Chol/GM1 = 96.2/0/3.8 mol %
6.47 0.48 5.18 0.95
DOPC/Chol + 4 % GM1
DOPC/Chol/GM1 = 67.3/28.8/3.8 mol %
6.77 0.64 5.96 0.78
DOPC/Chol + 4 % GM1 + CTxB
DOPC/Chol/GM1 = 67.3/28.8/3.8 mol %
4.50 0.50 4.38 0.24
856 R. Šachl et al. / Biochimica et Biophysica Acta 1853 (2015) 850–857Cholesterol involvement in the regulation of GM1 availability is
subjected to the density of GM1.While at lowGM1 contents cholesterol
reduces the recognition activity of GM1 (perhaps due to the suggested
tilted conformation [4] which is not suitable for binding), at higher
GM1 densities (~4 %) cholesterol ceases to have any impact on GM1-
ligand interaction. AtmediumGM1densities (1-2%GM1) the cholesterol
effect on down regulation of GM1 recognition activity gets ampliﬁed
which indicates cooperation between the two aspects. The cholesterol
content facilitates increase of GM1 density together with reduction of
its mobility within the GM1 pools which apparently disqualiﬁes it from
effective ligand recognition.
The nature of GM1 domains is severely affected upon binding of the
ligand. Seemingly, various labeled lipids (DiD) are no longer residing in
the domains bound by CTxB suggesting loss in permeability and much
tighter packing of the molecules inside the domains, accompanied by
lower DOPC level and reduction of the overall domain area. Cholesterol
present in the bilayer does not have an impact on GM1-ligand domains
at 4 % of GM1 at all. At lower GM1 level (~1 %) presence of cholesterol
mainly affects the overall area GM1-ligand domains occupy while
their size is not signiﬁcantly altered.
Physiological relevance of the clustering shown in this paper aswell as
in the earlier work of Shi et al. [5] depends on the level of GM1 that is nat-
urally present in plasma membrane of living cells. The highest level of
GSLs (fromwhich GM1 is themost frequent)was reported in cells of ner-
vous system, where they constitute almost 6 % of lipids [25]. The results
drawn on GM1, as they are related to the general phenomena of an oligo-
saccharide moiety in the headgroup region, may be possibly extended
also on other GSLs that may act with GM1 in a cooperative manner.
Eventually it is of note that despite the fact that our experiments
show signiﬁcant changes in receptor activity of GM1 upon clustering
and when cholesterol is involved, the activity is only reduced and
never completely turned off. We hypothesize that apart from the
clustering of GM1 and the cholesterol role we address here, various
other aspects such as the presence of unsaturated lipids or membrane
thickness can have a synergistic impact on the ganglioside recognition.
All our experiments were undertaken in highly ﬂuid, liquid disordered
bilayers. However, in real biological membranes, which are much
more rigid and ordered, all aspects affecting ganglioside organization
may have much larger impact as they are less disturbed by diffusion.
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